These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7246746)

  • 1. Role of vasopressin, catecholamines, and plasma volume in hypertonic saline-induced hypertension.
    Hatzinikolaou P; Gavras H; Brunner HR; Gavras I
    Am J Physiol; 1981 Jun; 240(6):H827-31. PubMed ID: 7246746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for dopaminergic regulation of vasopressin release in the anephric rat.
    Hatzinikolaou P; Gavras H; North WG; Kohlmann O; Gavras I
    J Hypertens; 1984 Jun; 2(3):311-5. PubMed ID: 6442313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect.
    Burnier M; Biollaz J; Brunner DB; Gavras H; Brunner HR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):222-7. PubMed ID: 6129318
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction between AVP and sympathetic system in subtotal nephrectomy-saline hypertension: role of alpha and V1 receptors.
    Ozaykan B; Doğan A
    J Auton Nerv Syst; 2000 Jan; 78(2-3):165-71. PubMed ID: 10789696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of vasopressin to the maintenance of blood pressure in deoxycorticosterone-salt induced malignant hypertension in spontaneously hypertensive rats.
    Hiwatari M; Abrahams JM; Saito T; Johnston CI
    Clin Sci (Lond); 1986 Feb; 70(2):191-8. PubMed ID: 3956109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased susceptibility to salt-induced hypertension in subtotally nephrectomized mice lacking the vasopressin V1a receptor.
    Oikawa R; Hosoda C; Nasa Y; Daicho T; Tanoue A; Tsujimoto G; Takagi N; Tanonaka K; Takeo S
    Cardiovasc Res; 2010 Jul; 87(1):187-94. PubMed ID: 20118201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressor responses to intracisternal administration of hypertonic NaCl in conscious normotensive and spontaneously hypertensive rats.
    Takata Y; Yamashita Y; Nakao Y; Takishita S; Fujishima M
    Arch Int Pharmacodyn Ther; 1989; 299():110-26. PubMed ID: 2505699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressor response to vasopressin and norepinephrine in DOC-salt hypertensive and prehypertensive rats.
    Ouchi Y; Yazaki Y; Tsai RC; Ashida T
    Tohoku J Exp Med; 1988 Feb; 154(2):125-33. PubMed ID: 3381222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat.
    Okuno T; Winternitz SR; Lindheimer MD; Oparil S
    Am J Physiol; 1983 Jun; 244(6):H807-13. PubMed ID: 6407335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmotic stimulation in DOC-salt hypertension: vasopressin and blood pressure.
    Crofton JT; Share L; Brooks DP
    J Hypertens; 1986 Jun; 4(3):307-12. PubMed ID: 3734447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists.
    Filep J; Frölich JC; Földes-Filep E
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F952-8. PubMed ID: 3688242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute interaction of vasopressin and neurogenic mechanisms in DOC-salt hypertension.
    Matsuguchi H; Schmid PG
    Am J Physiol; 1982 Jan; 242(1):H37-43. PubMed ID: 7058911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressor response to vasopressin and impaired baroreflex function in DOC-salt hypertension.
    Matsuguchi H; Schmid PG
    Am J Physiol; 1982 Jan; 242(1):H44-9. PubMed ID: 7058912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats.
    Reid JL; Zivin JA; Kopin IJ
    Circ Res; 1975 Nov; 37(5):569-79. PubMed ID: 1192556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of vasopressin and other pressor systems to DOC-salt hypertension in rats.
    Mento PF; Wang HH; Sawyer WH
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):58-63. PubMed ID: 6694969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorrhage in DOC-salt hypertensive rats: plasma and platelet vasopressin.
    Crofton JT; Share L; Brooks DP
    Am J Physiol; 1985 Dec; 249(6 Pt 2):R726-31. PubMed ID: 4073293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central mechanisms in DOC-salt hypertensive rats.
    Matsuguchi H; Sharabi FM; O'Connor G; Mark AL; Schmid PG
    Clin Exp Hypertens A; 1982; 4(8):1303-21. PubMed ID: 7116668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of alpha(2)-adrenergic receptor subtypes in the acute hypertensive response to hypertonic saline infusion in anephric mice.
    Makaritsis KP; Johns C; Gavras I; Gavras H
    Hypertension; 2000 Feb; 35(2):609-13. PubMed ID: 10679505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of hypertension and bradycardia following lesions of the caudal ventrolateral medulla in the rabbit: the role of sympathetic nerves, circulating adrenaline, vasopressin and renin.
    Elliott JM; Kapoor V; Cain M; West MJ; Chalmers JP
    Clin Exp Hypertens A; 1985; 7(8):1059-82. PubMed ID: 2994915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.